Founder, CEO, and Chief Scientific Officer LIVMOR, Inc.
Experienced Chief Executive Officer in the biotechnology industry. Skilled in implantble medical device product development management, with over two decades expereince leading teams in the development of Cardiac Resynchronization Therapy devices, the worlds first Subcutaneous Implantable Defibrillator (S-ICD), and remote patient management systems specifically designed for patients with implantable devices.
Most recently founded LIVMOR a digital health start-up, and partnered with Samsung to co-develop a medical grade, fully integrated,
home-based patient care platform, providing continuous monitoring of patient cardiovascular system in virtually any setting.
Our system collects and transmits patient cardiac measurements to LIVMOR cloud services, providing both the patient and patient designated caregivers, physicians and clinicians, immediate access to securely protected patient health information. The core of LIVMOR’s platform is the first prescription-based, FDA regulated, fully automated smartwatch, that can detect all forms of Atrial Fibrillation.
Our medical grade smartwatch provides continuous monitoring of patients at high risk for asymptomatic (silent) paroxysmal
or sustained Atrial Fibrillation (AF). We are targeting patient populations with CHA₂DS₂-VASc score greater than 2 with or
without a current AF diagnosis. Our core expertise is the medically valid measurement of Heart Rate, Respiration Rate and
Rate Variability (HRV), which are valuable biomarkers for the early detection and management of several chronic diseases
including heart failure.
B. A. in Computer Science, Minor in Mathematics from University of Minnesota-Duluth.
Friday, July 10, 2020
6:00 PM – 7:00 PM MT